China
· Delayed Price · Currency is CNY China Resources Boya Bio-pharmaceutical Group Co.,Ltd Statistics
Total Valuation
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has a market cap or net worth of CNY 14.94 billion. The enterprise value is 9.71 billion.
| Market Cap | 14.94B |
| Enterprise Value | 9.71B |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | Oct 25, 2024 |
Share Statistics
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has 504.25 million shares outstanding. The number of shares has increased by 0.30% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 504.25M |
| Shares Change (YoY) | +0.30% |
| Shares Change (QoQ) | +2.11% |
| Owned by Insiders (%) | 3.80% |
| Owned by Institutions (%) | 15.59% |
| Float | 275.38M |
Valuation Ratios
The trailing PE ratio is 80.31 and the forward PE ratio is 25.44. China Resources Boya Bio-pharmaceutical Group Co.,Ltd's PEG ratio is 0.37.
| PE Ratio | 80.31 |
| Forward PE | 25.44 |
| PS Ratio | 8.76 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | 60.68 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.72, with an EV/FCF ratio of 39.43.
| EV / Earnings | 52.16 |
| EV / Sales | 5.69 |
| EV / EBITDA | 16.72 |
| EV / EBIT | 19.99 |
| EV / FCF | 39.43 |
Financial Position
The company has a current ratio of 12.01, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.01 |
| Quick Ratio | 10.84 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | 2,879.11 |
Financial Efficiency
Return on equity (ROE) is 2.46% and return on invested capital (ROIC) is 4.00%.
| Return on Equity (ROE) | 2.46% |
| Return on Assets (ROA) | 3.71% |
| Return on Capital (ROIC) | 4.00% |
| Revenue Per Employee | 1.18M |
| Profits Per Employee | 128,879 |
| Employee Count | 1,444 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.96 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.70% in the last 52 weeks. The beta is 0.38, so China Resources Boya Bio-pharmaceutical Group Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -10.70% |
| 50-Day Moving Average | 31.19 |
| 200-Day Moving Average | 31.97 |
| Relative Strength Index (RSI) | 36.05 |
| Average Volume (20 Days) | 4,534,862 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of CNY 1.71 billion and earned 186.10 million in profits. Earnings per share was 0.37.
| Revenue | 1.71B |
| Gross Profit | 1.13B |
| Operating Income | 485.58M |
| Pretax Income | 258.93M |
| Net Income | 186.10M |
| EBITDA | 576.90M |
| EBIT | 485.58M |
| Earnings Per Share (EPS) | 0.37 |
Balance Sheet
The company has 5.24 billion in cash and 4.61 million in debt, giving a net cash position of 5.23 billion or 10.38 per share.
| Cash & Cash Equivalents | 5.24B |
| Total Debt | 4.61M |
| Net Cash | 5.23B |
| Net Cash Per Share | 10.38 |
| Equity (Book Value) | 7.58B |
| Book Value Per Share | 15.03 |
| Working Capital | 6.04B |
Cash Flow
In the last 12 months, operating cash flow was 378.43 million and capital expenditures -132.22 million, giving a free cash flow of 246.21 million.
| Operating Cash Flow | 378.43M |
| Capital Expenditures | -132.22M |
| Free Cash Flow | 246.21M |
| FCF Per Share | 0.49 |
Margins
Gross margin is 66.05%, with operating and profit margins of 28.45% and 10.90%.
| Gross Margin | 66.05% |
| Operating Margin | 28.45% |
| Pretax Margin | 15.17% |
| Profit Margin | 10.90% |
| EBITDA Margin | 33.80% |
| EBIT Margin | 28.45% |
| FCF Margin | 14.43% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 1.08%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 1.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 81.29% |
| Buyback Yield | -0.30% |
| Shareholder Yield | 0.78% |
| Earnings Yield | 1.25% |
| FCF Yield | 1.65% |
Stock Splits
The last stock split was on May 26, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has an Altman Z-Score of 18.37.
| Altman Z-Score | 18.37 |
| Piotroski F-Score | n/a |